Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the synthetic hormones market?

The synthetic hormones market has seen strong growth, projected to increase from $6.38 billion in 2024 to $6.77 billion in 2025 at a CAGR of 6.2%. Historical growth has been driven by the use of synthetic hormones in animal growth promotion, performance enhancement, fertility treatments, menopause management, and concerns over environmental impact.

What will be the synthetic hormones market size in the future?

The synthetic hormones market is poised for steady expansion, reaching $8.15 billion in 2029 at a CAGR of 4.7%. Growth is fueled by the expansion of transgender healthcare, increased healthcare spending, regulatory approvals, and broader synthetic hormone applications. Key trends include plant-based hormone therapy, integration in anti-aging treatments, drug delivery advancements, and hormone-free birth control solutions.

Get your synthetic hormones market report here!

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

What main drivers are fueling expansion in the synthetic hormones market?

The surging instances of hormonal irregularities are anticipated to boost the expansion of the synthetic hormones market in the future. Hormonal imbalance, which entails having an excess or deficiency of a hormone in the bloodstream, can be caused by stress, aging, medical conditions, or lifestyle decisions, interrupting the standard production and regulation of hormones in the body. Synthetic hormones play a crucial role in supplementing or substituting natural hormones in hormonal imbalances, hence helping in managing bodily functions and mitigating symptoms linked with deficiencies or surpluses. For instance, the NHS Business Services Authority, a non-departmental public body based in the UK, revealed that approximately 7.80 million hormone replacement therapy (HRT) items were given out in England in 2022, recording a 35.0% surge from the previous year. As such, the escalating instances of hormonal imbalances are fueling the expansion of the synthetic hormones market.

What key areas define the segmentation of the global synthetic hormones market?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Who are the dominant players expanding their reach in the synthetic hormones market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

How are evolving market trends shaping synthetic hormones Strategies?

Principal firms in the synthetic hormone market, like Pfizer Inc. and OPKO Health Inc., are concentrating on the creation of unique products such as recombinant human growth hormone to enhance their market profitability. Recombinant human growth hormone serves as a treatment for children and adults with growth hormone deficiencies, as well as other medical conditions related to a lack of growth hormone. In February 2022, these two US-based companies, one a pharmaceutical giant and the other a medicinal test and medication firm, obtained approval in the European Union for their once-weekly NGENLA (somatrogon) injections. With the intention to address pediatric growth hormone deficiencies in children and adolescents aged three or older, this innovative long-acting injection serves as an alternative treatment for growth impediments due to inadequate growth hormone. Unlike daily growth hormone injections, NGENLA can be administered subcutaneously and possesses a longer-effective period in the body, thus requiring only weekly assistance.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14515

Which regions are emerging as leaders in the synthetic hormones market?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Geosynthetics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/geosynthetics-global-market-report

Synthetic Fibers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-fibers-global-market-report

Synthetic Latex Polymers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-latex-polymers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: